Vishal Doshi – AUM Biosciences, AI and the Cure for Cancer
Get My Playbook for Digital Transformation
Free 30 Page Ebook Containing Data + Case Studies
Experts predict Asia's travel market will grow 56% to $670 billion by 2024. CEO Tony Fernandes has already set out a Digital Transformation strategy that will evolve AirAsia from being an airline to a digital travel company. It's a bold challenge, but one with the right leadership and vision in place. In my playbook for change, "The Digital Transformation Story" I share case studies of brands who are facing the digital transformation challenge, a challenge that is ultimately about people not digital.
In this disruptive shift from Industrial to Digital, Pipeline to Platform, companies will need to adapt from the Big Idea to Big Data. Communication will shift from the external buying of attention to internal storytelling to create innovative tribes of purpose within their ecosystems.
In a world infatuated by the latest shiny technology it’s easy to lose sight of the key challenges facing our time – like finding a cure for cancer.
The drug discovery process is both expensive and by nature highly wasteful. Less than 5% of drugs under development ever reach the mass market. But that doesn’t mean the 95% are not worthy of public consumption, it just means the economics didn’t make sense for larger pharmaceuticals. AUM Biosciences wants to change that. By applying AI and Big Data technology to the extensive data sets generated by pharmaceutical companies, AUM hopes to sift through the drugs that didn’t make the mass market and revisit those that could work under different conditions. Could this mean access to cheaper drugs? Could this mean we also see Asia driving drug discovery and innovation in the future?